VI
ONC icon

Vestcor Inc’s BeOne Medicines Ltd ONC Stock Holding History

Vestcor Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,061
Closed -$200K – 1476
2022
Q1 		$200K Sell
1,061
-2,124
-67% -$452K 0.01% 933
2021
Q4 		$863K Hold
3,185
– – 0.03% 493
2021
Q3 		$1.16M Buy
3,185
+2,345
+279% +$767K 0.04% 397
2021
Q2 		$288K Buy
+840
New +$278K 0.01% 783
2020
Q4 		– Sell
-1,018
Closed -$292K – 1033
2020
Q3 		$292K Hold
1,018
– – 0.01% 584
2020
Q2 		$192K Sell
1,018
-175
-15% -$28.5K 0.01% 604
2020
Q1 		$147K Buy
1,193
+614
+106% +$96K 0.01% 677
2019
Q4 		$96K Buy
+579
New +$96.2K ﹤0.01% 779

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Vestcor Inc's ONC Position: Q2 2022 in Review

Vestcor Inc sold out of BeOne Medicines Ltd (ONC) in Q2 2022, closing a stake of 1,061 shares — an estimated $200K sold.

Vestcor Inc first reported a position in ONC in Q4 2019 and held it in 8 quarters. The position peaked at $1.16M in Q3 2021. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

  • Vestcor Inc reported no remaining BeOne Medicines Ltd position as of Q2 2022 after selling out during the quarter.
  • Vestcor Inc sold 1,061 BeOne Medicines Ltd shares in Q2 2022, an estimated $200K.
  • Vestcor Inc first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 8 quarters.
  • Vestcor Inc's BeOne Medicines Ltd position peaked at $1.16M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Vestcor Inc's 13F filing for Q2 2022, filed 15 Aug 2022.